Scalp cooling reduces chemotherapy-induced alopecia

Pioneers in Scalp Cooling

Paxman have been pioneering scalp cooling technology for over a quarter of a century to support patients and minimize hair loss during chemotherapy. Our clinically proven scalp cooling system helps tens of thousands of cancer patients every year, in more than 60 countries worldwide, to retain their hair during chemotherapy.
Together, we make a difference.
About Us

and Safety

Efficacy varies based on a series of factors, with the chemotherapy drug regimens being the primary factor. Taxane based regimens see the highest rates of hair retention, and although anthracycline regimens see a lower level of efficacy, scalp cooling with anthracyclines is still beneficial.
Learn More

Science and Research

The Biological Mechanisms of Scalp Cooling. Biological research on scalp cooling, has been focused on exploring the hypothesis that cooling reduces the entry of chemotherapy drugs into human keratinocytes.
Learn More
  • The Scalp Cooling Study Library

    The Scalp Cooling Study Library unites key clinical research studies and data to provide an independent overview of global research and practice on scalp cooling and cryotherapy for chemotherapy side effect management.
  • Paxman
    Patient Support is there to help patients make an informed choice and guide them through their scalp cooling treatment.
  • We are global leaders in scalp cooling, on an ambitious and exciting journey to change the face of cancer.

    About Paxman
  • The Paxman Scalp Cooling System

    The Paxman Scalp Cooling System provides the leading scalp-cooling technology for preventing chemotherapy-induced alopecia.
    Learn More
© Paxman Coolers 2022